Low Expression of CD5 and CD6 Is Associated with Poor Overall Survival for Patients with T-Cell Malignancies

Figure 2

OS analysis of CD5 and CD6 in TCM patients in the training and validation cohorts. (a-b) Comparison of the CD5 and CD6 expression levels in healthy individuals (HIs) and T-ALL (a) or TCL (b) patients. (c-d) After the cut-off values were determined by X-tile software (left panel), Kaplan–Meier curves (right panel) were plotted according to subgroups of low and high CD5 expression in the training (c) and validation (d) cohorts. (e-f) Based on the cut-off values for CD6 (left panel), the TCM patients were divided into low and high CD6 expression groups, and the Kaplan–Meier curves (right panel) were plotted in the training (e) and validation (f) cohorts.

(a)

(b)

(c)

(d)

(e)

(f)